Aceso Life Science Group Limited (HKG:0474)

Aceso Life Science Group Statistics

Total Valuation

HKG:0474 has a market cap or net worth of HKD 885.81 million.

Market Cap	885.81M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:0474 has 7.38 billion shares outstanding. The number of shares has increased by 0.98% in one year.

Current Share Class	7.38B
Shares Outstanding	7.38B
Shares Change (YoY)	+0.98%
Shares Change (QoQ)	+1.27%
Owned by Insiders (%)	56.68%
Owned by Institutions (%)	0.02%
Float	2.00B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-15.82
PB Ratio	2.39
P/TBV Ratio	2.39
P/FCF Ratio	7.64
P/OCF Ratio	7.70
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 3.32.

Current Ratio	1.98
Quick Ratio	1.86
Debt / Equity	3.32
Debt / EBITDA	n/a
Debt / FCF	10.59
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.44% and return on invested capital (ROIC) is -19.21%.

Return on Equity (ROE)	-51.44%
Return on Assets (ROA)	-16.94%
Return on Invested Capital (ROIC)	-19.21%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	-1.37M
Profits Per Employee	-9.07M
Employee Count	123
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-4.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +144.90% in the last 52 weeks. The beta is -0.47, so HKG:0474's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	+144.90%
50-Day Moving Average	0.12
200-Day Moving Average	0.06
Relative Strength Index (RSI)	53.90
Average Volume (20 Days)	2,881,099

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:0474 had revenue of HKD -56.00 million and -372.00 million in losses. Loss per share was -0.05.

Revenue	-56.00M
Gross Profit	-161.00M
Operating Income	-307.00M
Pretax Income	-521.00M
Net Income	-372.00M
EBITDA	n/a
EBIT	n/a
Loss Per Share	-0.05

Balance Sheet

The company has 305.00 million in cash and 1.23 billion in debt, with a net cash position of -923.00 million or -0.13 per share.

Cash & Cash Equivalents	305.00M
Total Debt	1.23B
Net Cash	-923.00M
Net Cash Per Share	-0.13
Equity (Book Value)	370.00M
Book Value Per Share	0.05
Working Capital	224.00M

Cash Flow

In the last 12 months, operating cash flow was 115.00 million and capital expenditures 1.00 million, giving a free cash flow of 116.00 million.

Operating Cash Flow	115.00M
Capital Expenditures	1.00M
Free Cash Flow	116.00M
FCF Per Share	0.02

Margins

Gross Margin	n/a
Operating Margin	548.21%
Pretax Margin	930.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:0474 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.98%
Shareholder Yield	-0.98%
Earnings Yield	-42.00%
FCF Yield	13.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 12, 2017. It was a forward split with a ratio of 1.166666667.

Last Split Date	Jul 12, 2017
Split Type	Forward
Split Ratio	1.166666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	3